Ammann P, Rizzoli R, Müller K, Slosman D, Bonjour J P
Division of Clinical Pathophysiology, University Hospital, Basel, Switzerland.
Am J Physiol. 1993 Nov;265(5 Pt 1):E770-6. doi: 10.1152/ajpendo.1993.265.5.E770.
Effects induced by insulin-like growth factor I (IGF-I) and/or the bisphosphonate pamidronate (APD) on bone mineral density (BMD) of the lumbar spine and proximal and midshaft tibia were studied in adult rats made osteopenic by ovariectomy, using dual-energy X-ray absorptiometry. IGF-I, which was administered by osmotic minipumps implanted subcutaneously for 6 wk, caused a dose-dependent increase of BMD at the three investigated sites. A 4-wk course of IGF-I, followed by intermittent cyclical APD administration, induced significant increases of BMD at the levels of spine and proximal tibia. At midshaft tibia, where cortical bone predominates, BMD was increased by IGF-I only. In conclusion, IGF-I increased BMD at sites with trabecular and/or cortical bone, whereas the APD influence was mainly detectable in the former site only.
采用双能X线吸收法,研究了胰岛素样生长因子I(IGF-I)和/或双膦酸盐帕米膦酸二钠(APD)对去卵巢所致成年骨质疏松大鼠腰椎、胫骨近端和中段骨密度(BMD)的影响。通过皮下植入渗透微型泵持续6周给予IGF-I,在三个研究部位均引起BMD呈剂量依赖性增加。先给予4周的IGF-I,随后间歇性周期性给予APD,可使脊柱和胫骨近端的BMD显著增加。在以皮质骨为主的胫骨中段,仅IGF-I可增加BMD。总之,IGF-I可增加含有小梁骨和/或皮质骨部位的BMD,而APD的影响主要仅在前者部位可检测到。